Milestone Scientific (MLSS) Non-Current Debt (2010 - 2025)

Milestone Scientific (MLSS) posted Non-Current Debt of $800000.0 for Q2 2025, up 77.78% sequentially from $450000.0 in Q2 2013.

Milestone Scientific (MLSS) Non-Current Debt (2010 - 2025) Analysis & Trends

Milestone Scientific has reported Non-Current Debt for 5 years, with the latest figure at $800000.0 in Q2 2025.

Quarterly Non-Current Debt changed N/A year-over-year to $800000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $800000.0 (changed N/A YoY) and the FY2012 annual result came in at $450000.0, up 0.69% from the prior year.
Non-Current Debt climbed to $800000.0 in Q2 2025 per MLSS's latest filing, from $450000.0 in the prior quarter.
Over five years, Non-Current Debt peaked at $800000.0 in Q2 2025 and troughed at $800000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	-
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	13.51 Bn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	4.15 Bn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	399.42 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	12.55 Bn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	202.90 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	4.57 Bn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	1.86 Bn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	8.62 Bn
10	Milestone Scientific	39.41 Mn	36.80 Mn	1.56 Mn	-

Download Data